No Data
No Data
Express News | Metavia Inc : Maxim Group Cuts Target Price to $6 From $10
Positive Outlook on MetaVia's Promising Pipeline and Strategic Growth Despite Market Challenges
H.C. Wainwright Maintains MetaVia(MTVA.US) With Buy Rating, Maintains Target Price $12
MetaVia Inc. Reports Progress in Cardiometabolic Drug Development
Express News | HC Wainwright & Co. Reiterates Buy on MetaVia, Maintains $12 Price Target
MetaVia's Promising Clinical Developments and Strategic Advancements Drive Buy Recommendation